Facebook Facebook Share
Posted by Target Ovarian Cancer on Tuesday 8 September 2015

Target Ovarian Cancer is extremely proud to announce that our symptoms leaflet has been highly commended in this year’s British Medical Association (BMA) Patient Information Awards.

Our symptoms leaflet is one of our core pieces of information to help improve early diagnosis for women concerned about symptoms. First launched in 2009, it has been updated regularly to adhere to the latest national guidance and Information Standard, and has been produced in consultation with both health experts and women with ovarian cancer.

The leaflet is used as part of our expanding portfolio of symptoms information, which also includes symptoms posters, stickers, our symptoms film, our 10 Top Tips to help women talk to their GPs and our recently launched Symptoms Diary app. The symptoms leaflet has been used to support an awareness campaign in Northern Ireland run by the Public Health Agency, and is available in a number of different languages.

Annwen Jones, Chief Executive at Target Ovarian Cancer, said: “We are delighted that one of our most essential resources for women has won this award. We’re proud of our range of symptoms resources, and that such a prestigious organisation as the BMA has recognised their value. Improving early diagnosis is essential to improving survival rates for ovarian cancer, and increasing awareness of symptoms is a very important step.”

Sue Betts, who tells her story of diagnosis in the symptoms leaflet and attended the award ceremony yesterday, said: “All women should know the symptoms of ovarian cancer and visit their GP at the earliest opportunity. I’d explained away each symptom as a minor problem. I’ve used Target Ovarian Cancer’s symptoms leaflet to raise awareness in my own community and it is wonderful to see it being recognised in this way.”

Useful links

  • Download our symptoms leaflet, or order copies to share within your local community.
  • The BMA Patient Information Awards were established in 1997 to encourage excellence in the production and dissemination of accessible, well-designed and clinically balanced patient information.
  • Find out more about awards that Target Ovarian Cancer has received.